Therapeutic efficacy and safety of dihydroartemisinin-piperaquine [DP] for the treatment of uncomplicated plasmodium vivax malaria: a single center study

ABSTRACT

Background: Ninety-five millions of Pakistan's 161 million people, roughly 60% of Pakistan's population live in malaria endemic regions. Despite a well-established malaria control programme, 500,000 malaria infections and 50,000 malaria-attributable deaths occur each year in Pakistan. In Pakistan 15% population lives in high transmission area, 84% in low transmission and 1% in malaria free area, with 64% vivax and 36% Falciparum infections